A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and β-amyloid plaques in a mouse model of Alzheimer's disease

Autor: Jianmin Zhang, Xiaobing Wu, Chuan Qin, Jin Qi, Shibin Ma, Huiyuan Zhang, Qingli Kong, Dongqing Chen, Denian Ba, Wei He
Jazyk: angličtina
Rok vydání: 2003
Předmět:
Zdroj: Neurobiology of Disease, Vol 14, Iss 3, Pp 365-379 (2003)
Druh dokumentu: article
ISSN: 1095-953X
DOI: 10.1016/j.nbd.2003.07.005
Popis: Memory impairment progressing to dementia is the main clinical symptom of Alzheimer's disease (AD). Deposition of the amyloid-β peptide (Aβ) in brain, particularly its 42-amino acid isoform (Aβ42), has been shown to play a primary and crucial role in the pathogenesis of AD. In this study we have developed a recombinant adeno-associated virus (AAV) vaccine against AD. This vaccine could express CB-Aβ42 (cholera toxin B subunit and Aβ42 fusion protein) in vivo. A single administration of the AAV-CB-Aβ42 vaccine induced a prolonged, strong production of Aβ-specific serum IgG in transgenic mice that overexpressed the London mutant of amyloid precursor protein (APP/V717I), and resulted in improved ability of memory and cognition, decreased Aβ deposition in the brain, and a resultant decrease in plaque-associated astrocytosis. Our results extended the immunological approaches for the treatment and prevention of AD to an oral, intranasal, or intramuscular route that might be better tolerated in human patients than repetitive parental immunizations in the presence of adjuvant. AAV has attracted tremendous interest as a promising vector for gene delivery. Our results raised the possibility that AAV-CB-Aβ42 vector immunization may provide the basis of a novel and promising Alzheimer's disease vaccination program.
Databáze: Directory of Open Access Journals
Externí odkaz: